Bud Genius Announces Intention to Repurchase More Company Shares

Company is considering repurchase of up to 2 billion shares

Bud Genius, Inc. (www.bgmedtech.com) (OTC: RIGH), a leading laboratory for cannabis testing and profiling, developer of data-driven rating systems for marijuana strains, brand and retail development specialist, and licensee of celebrity-endorsed marijuana and hemp related merchandise, announced today that the company is considering a share repurchase of up to 2 billion shares.

“The company may have an opportunity to buy shares of its own stock at a favorable price. This buyback consideration represents our continued confidence in our growth strategy and ability to generate new revenues,” said Angel Stanz, Bud Genius CEO.

Bud Genius’ share repurchasing may be made in open market or through privately negotiated transactions, subject to market conditions, applicable legal requirements, and other relevant factors.

For more information on Bud Genius, call (855) 723-3283, or visit BGMedtech.com.

About Bud Genius:

An early leader in the cannabis industry, Bud Genius is one of the first established analytical cannabis laboratories in the United States. Bud Genius launched to bring vendors together with doctors, patients, and dispensaries that require certified products held to demanding standards. Bud Genius’ mission is to expand across the US and abroad, serving as the beacon of quality for medical cannabis and adult-use marijuana through the formation of regional laboratories, strain certification, data collection, online reporting, and product development.

For more information please visit: www.BGMedtech.com

Visit the cannabis showroom at: www.BudGenius.com

Connect:

Website: www.BGMedtech.comTwitter: Twitter.com/BudGeniusCannabis Showroom: www.BudGenius.com

Forward Looking Statements:

This press announcement includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of company’s management and are subject to significant risks and uncertainties. Forward-looking statements can be identified by such terminology as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, competitive factors, and other matters. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Bud Genius, Inc.Randall Huft, 855-723-3283Public RelationsRandall@BudGenius.com

RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Oct 2024 to Nov 2024